Contrasting Chemours (CC) & The Competition

Chemours (NYSE:CC) is one of 295 public companies in the “Chemicals” industry, but how does it compare to its competitors? We will compare Chemours to related companies based on the strength of its analyst recommendations, risk, profitability, earnings, valuation, dividends and institutional ownership.

Profitability

This table compares Chemours and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Chemours	-5.00%	60.64%	1.48%
Chemours Competitors	-61.06%	1.32%	-1.40%

Risk and Volatility

Chemours has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500. Comparatively, Chemours’ competitors have a beta of 1.26, suggesting that their average stock price is 26% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Chemours and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	1	9	3	0	2.15
Chemours Competitors	3237	12176	14100	515	2.40

Chemours currently has a consensus price target of $17.73, indicating a potential upside of 34.28%. As a group, “Chemicals” companies have a potential upside of 6.18%. Given Chemours’ higher possible upside, research analysts plainly believe Chemours is more favorable than its competitors.

Insider and Institutional Ownership

76.3% of Chemours shares are owned by institutional investors. Comparatively, 48.0% of shares of all “Chemicals” companies are owned by institutional investors. 0.9% of Chemours shares are owned by insiders. Comparatively, 14.1% of shares of all “Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Dividends

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.7%. Chemours pays out -18.3% of its earnings in the form of a dividend. As a group, “Chemicals” companies pay a dividend yield of 3.1% and pay out 107.7% of their earnings in the form of a dividend.

Valuation and Earnings

This table compares Chemours and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Chemours	$5.81 billion	-$386.00 million	-6.91
Chemours Competitors	$7.96 billion	$222.31 million	-3.71

Chemours’ competitors have higher revenue and earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Chemours competitors beat Chemours on 8 of the 15 factors compared.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.